InvestorsHub Logo
icon url

Hookmeistr

03/05/21 11:30 AM

#150150 RE: SF Anony #150143

But some people only want to focus on the fact that CytoDyn has not yet received an approval. I must sound like a broken record by now, but I’ll say it again: That fact is true for EVERY SINGLE BIOTECH COMPANY in existence at some point in their existence. Every company has a period of time during which it has not gotten a drug approved.



The comment about sounding like a broken record could also be said about the same people who only focus on the fact that Cydodyn has not yet received an approval. Of course the operative word there is "YET."

The trend is your friend until it's not is a favorite saying of mine when analyzing charts for day trading. It also holds true for the shorts.

Great post SF Anony....
icon url

dadbrotheroftwins

03/05/21 1:57 PM

#150165 RE: SF Anony #150143

Thank you SF Anony. I believe you are right, but for me the risks and questions remain. FDA has known all along the efficacy due to OLE and eIND. I think that they could have given EUA right away once they received data. They didn't. Discussions regarding distribution etc do not hinder EUA. That can be decided after the fact. Hence for me I've reduced my exposure because I think FDA will not give CYDY outright EUA, only that that CYDY will have to pony up and play ball with a big BP and sell to them at a reduced rate to get it to market through their distribution channels. Less revenue to impact BP's bottom line and they get a big cut.